8-K: RxSight, Inc. Holds Annual Meeting, Re-elects Directors

Sentiment:

Submission of Matters to a Vote of Security Holders 16 June 2026 4:30 PM

RxSight, Inc. announced the results of its 2026 Annual Meeting of Stockholders, including the re-election of three Class II directors and the ratification of its independent auditor.

Summary

RxSight, Inc. held its 2026 Annual Meeting of Stockholders on June 16, 2026.
Approximately 80.4% of outstanding common stock was represented at the meeting.
Three Class II directors, William J. Link, Robert Warner, and Shweta Singh Maniar, were re-elected.
Stockholders approved, on an advisory basis, the compensation of named executive officers.
The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive filing due to the strong shareholder participation and clear outcomes in key governance matters, indicating stability and alignment.

Positives

High shareholder participation with 80.4% of outstanding shares represented.
Re-election of all three Class II director nominees with significant 'For' votes.
Strong approval for the advisory vote on executive compensation.
Unanimous ratification of Ernst & Young LLP as the independent auditor.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that the high shareholder turnout and strong voting results for director elections and auditor ratification are typical for established public companies and indicate general shareholder confidence in the current board and oversight.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Director Election	Re-election of three Class II directors: William J. Link, Robert Warner, and Shweta Singh Maniar.	June 16, 2026	Maintains continuity in board leadership and strategy.
Advisory Vote on Executive Compensation	Stockholders approved, on an advisory basis, the compensation of named executive officers.	June 16, 2026	Indicates shareholder support for current executive compensation practices.
Independent Auditor Ratification	Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.	June 16, 2026	Confirms continued engagement with a major accounting firm for financial audit.

Stakeholder Impact

Shareholders: Re-election of directors and approval of executive compensation affirm current governance and management structure.
Employees: Stability in leadership and compensation practices can contribute to a stable work environment.
Creditors: Continued engagement of a reputable auditor provides assurance on financial reporting.

Next Steps

The re-elected Class II directors will serve until the 2029 annual meeting.
Ernst & Young LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

Key Dates

Date	Description
April 21, 2026	Record date for determining stockholders entitled to vote at the Annual Meeting.
June 16, 2026	Date of the 2026 Annual Meeting of Stockholders and the date of the report.
December 31, 2026	Fiscal year end for which Ernst & Young LLP was appointed as independent registered public accounting firm.
2029	Term end for re-elected Class II directors.

Keywords

RxSight, Annual Meeting, Stockholders, Director Election, Executive Compensation, Independent Auditor, Ernst & Young LLP, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.